NCT06471374

Brief Summary

The goal of this study is to understand factors that contribute to delayed sleep wake phase disorder (DSWPD). The investigators will examine whether patients with DSWPD exhibit alterations in circadian rhythms and sensitivity to light compared to healthy controls. The investigators will also test a new method of predicting circadian rhythms form a blood sample.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
66

participants targeted

Target at P50-P75 for not_applicable

Timeline
26mo left

Started Apr 2024

Longer than P75 for not_applicable

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress49%
Apr 2024Jul 2028

Study Start

First participant enrolled

April 2, 2024

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

June 18, 2024

Completed
6 days until next milestone

First Posted

Study publicly available on registry

June 24, 2024

Completed
4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2028

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2028

Last Updated

June 28, 2024

Status Verified

June 1, 2024

Enrollment Period

4.2 years

First QC Date

June 18, 2024

Last Update Submit

June 26, 2024

Conditions

Outcome Measures

Primary Outcomes (4)

  • Core body temperature

    Body temperature measured with a pill

    Continuously for 1. up to 39 and 2. 23 hours

  • Glucose

    Blood sugar levels

    Continuously for 1. up to 39 and 2. 23 hours

  • Subjective sleepiness

    Self reported sleepiness

    Every 2 hours

  • Psychomotor vigilance

    Attention/Vigilance performance

    Every 2 hours

Secondary Outcomes (2)

  • Skin temperature

    Continuously for 1. up to 39 and 2. 23 hours

  • Melatonin

    Hourly for 1. up to 39 hours and 2. every 20 minutes

Study Arms (1)

Assessment

EXPERIMENTAL

Circadian rhythms and light sensitivity

Behavioral: Circadian rhythm assessmentBehavioral: Light sensitivity assessment

Interventions

Participants will arrive approximately 8 hours before participant's scheduled bedtime to practice ability to think testing and a 9-hour sleep study. Participants will live in the laboratory for approximately 66 hours (2.75 days). Upon awakening in the morning, participants will start a routine of up to 39 hours of wakefulness, under bedrest conditions. Saliva will be sampled frequently and blood will be drawn 3 times. Reaction time, ability to think, and subjective rating tests will be performed frequently. Participants will be provided scheduled bathroom breaks when participants will use a commode next to the bed. Outside these scheduled bathroom breaks, participants will be provided a bedpan to use to go to the bathroom. At the end of the research procedures for Visit 4 participants will be given a recovery sleep opportunity and be discharged from the lab in the morning near participant's typical waketime.

Assessment

Participants will arrive in the afternoon to practice ability to think testing and a 9-hour sleep study. Participants will live in the laboratory for approximately 48 hours (2 days). Upon awakening in the morning, participants will be exposed to dim candlelight and then later in the day alternating intensities of dim and room light when we keep participants awake for up to 23 hours (We will ask participants to remain in bed seated for \~12.5 hours). Saliva will be sampled frequently. Reaction time, ability to think, and subjective rating tests will be performed frequently. Participants will then have a second 9-hour sleep opportunity.

Assessment

Eligibility Criteria

Age16 Years - 30 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Delayed sleep wake phase disorder diagnosis
  • Altitude history: currently residing at Denver altitude or higher
  • BMI normal to moderately overweight

You may not qualify if:

  • Recent medical condition
  • Psychiatric disorder
  • Sleep disorder
  • Medication use

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

University of Colorado

Boulder, Colorado, 80303, United States

RECRUITING

Northwestern University

Chicago, Illinois, 60611, United States

RECRUITING

MeSH Terms

Conditions

Sleep Disorders, Circadian Rhythm

Condition Hierarchy (Ancestors)

Chronobiology DisordersNervous System DiseasesDyssomniasSleep Wake DisordersOccupational DiseasesMental Disorders

Study Officials

  • Kenneth Wright, PhD

    University of Colorado, Boulder

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Kenneth Wright, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

June 18, 2024

First Posted

June 24, 2024

Study Start

April 2, 2024

Primary Completion (Estimated)

July 1, 2028

Study Completion (Estimated)

July 1, 2028

Last Updated

June 28, 2024

Record last verified: 2024-06

Locations